What is Universe Pharmaceuticals Inc?
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
UPC · Verdict
Limited reward · elevated risk
UPC's standout is balance sheet; profitability and growth weigh on the picture.
Based on 88% data coverage
UPC · Verdict
Current ratio 4.07
-21% net margin · -7% ROE
Rev -23.7% CAGR · earnings -25.1%
-30% free-cash-flow margin
Weak vs peers
Model-based scoring. For information only — not financial advice.
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.53M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.